These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10174453)

  • 21. How global brands compete.
    Holt DB; Quelch JA; Taylor EL
    Harv Bus Rev; 2004 Sep; 82(9):68-75, 136. PubMed ID: 15449856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A blueprint for green marketing.
    Davis JJ
    J Bus Strategy; 1991; 12(4):14-7. PubMed ID: 10112307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The benefits of strategic naming.
    Chajet C
    J Bus Strategy; 1991; 12(5):61-4. PubMed ID: 10114522
    [No Abstract]   [Full Text] [Related]  

  • 24. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?
    Wen CP; Chen T; Tsai YY; Tsai SP; Chung WS; Cheng TY; Levy DT; Hsu CC; Peterson R; Liu WY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i38-44. PubMed ID: 15923447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loyalty-based management.
    Reichheld FF
    Harv Bus Rev; 1993; 71(2):64-73. PubMed ID: 10124634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategic options for brand-name prescription drugs when patents expire.
    Mehta SC; Mehta SS
    Health Mark Q; 1997; 14(3):107-14. PubMed ID: 10167309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does brand differentiate pharmaceuticals?
    Bednarik J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Take command of your growth.
    Treacy M; Sims J
    Harv Bus Rev; 2004 Apr; 82(4):127-33, 142. PubMed ID: 15077373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four strategies for the age of smart services.
    Allmendinger G; Lombreglia R
    Harv Bus Rev; 2005 Oct; 83(10):131-4, 136, 138 passim. PubMed ID: 16250631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What becomes an icon most?
    Holt DB
    Harv Bus Rev; 2003 Mar; 81(3):43-9. PubMed ID: 12632803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How the industry is marketing menthol cigarettes: the audience, the message and the medium.
    Richardson A; Ganz O; Pearson J; Celcis N; Vallone D; Villanti AC
    Tob Control; 2015 Nov; 24(6):594-600. PubMed ID: 25178275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing hybrid marketing systems.
    Moriarty RT; Moran U
    Harv Bus Rev; 1990; 68(6):146-55. PubMed ID: 10107959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored logistics: the next advantage.
    Fuller JB; O'Conor J; Rawlinson R
    Harv Bus Rev; 1993; 71(3):87-98. PubMed ID: 10126157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. If brands are built over years, why are they managed over quarters?
    Lodish LM; Mela CF
    Harv Bus Rev; 2007; 85(7-8):104-12, 192. PubMed ID: 17642129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond offshoring: assess your company's global potential.
    Farrell D
    Harv Bus Rev; 2004 Dec; 82(12):82-90, 148. PubMed ID: 15605568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The temporal relationship between advertising and sales of low-tar cigarettes.
    Reed MB; Anderson CM; Burns DM
    Tob Control; 2006 Dec; 15(6):436-41. PubMed ID: 17130371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three questions you need to ask about your brand.
    Keller KL; Sternthal B; Tybout A
    Harv Bus Rev; 2002 Sep; 80(9):80-6, 125. PubMed ID: 12227148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blue ocean strategy.
    Kim WC; Mauborgne R
    Harv Bus Rev; 2004 Oct; 82(10):76-84, 156. PubMed ID: 15559577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Your most valuable asset. Increasing the value of your hospital through its brand.
    Petromilli M; Michalczyk D
    Mark Health Serv; 1999; 19(2):4-9. PubMed ID: 10557756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.